Filter
602
Filtered Results: 602
Text search:
lepra
Featured
Recommendations
62
New Publications
89
Language
Document type
No document type
211
Studies & Reports
142
Guidelines
111
Strategic & Response Plan
49
Manuals
39
Training Material
17
Fact sheets
16
Situation Updates
7
Brochures
6
Infographics
3
Resource Platforms
1
Countries / Regions
Senegal
49
India
34
Burkina Faso
32
Global
25
Germany
22
Paraguay
17
Benin
12
Congo, Democratic Republic of
12
Colombia
11
Latin America and the Carribbean
11
Cameroon
9
Argentina
9
Western and Central Europe
8
Central African Republic
7
Kenya
6
Bolivia
6
Guinea
5
Africa
5
Haiti
5
West and Central Africa
5
Nepal
4
Ethiopia
4
Mali
4
Indonesia
4
Liberia
4
Rwanda
3
Nigeria
3
Cambodia
3
Asia
3
Venezuela
3
East and Southern Africa
3
Côte d’Ivoire / Ivory Coast
3
Bangladesh
3
Russia
3
El Salvador
2
Sierra Leone
2
Malawi
2
Philippines
2
Tanzania
2
South–East Asia Region
2
South Africa
2
Vietnam
2
Uganda
2
Eastern Europe
2
Zambia
2
South Sudan
2
Switzerland
1
Thailand
1
Ukraine
1
Lesotho
1
Syria
1
Niger
1
Afghanistan
1
Burundi
1
Peru
1
Zimbabwe
1
Morocco
1
Mozambique
1
Western Pacific Region
1
North America
1
Portugal
1
Papua New Guinea
1
Somalia
1
Eswatini/ Swaziland
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
253
Clinical Guidelines
58
Public Health
35
Women & Child Health
28
Key Resources
18
Capacity Building
7
Pharmacy & Technologies
3
Toolboxes
NTDs
100
TB
46
Caregiver
37
COVID-19
34
Disability
24
Malaria
18
Refugee
17
Global Health Education
16
HIV
15
Ebola & Marburg
14
Planetary Health
11
Mental Health
10
AMR
9
Social Ethics
6
Health Financing Toolbox
6
Conflict
6
Pharmacy
5
Polio
5
NCDs
4
Rapid Response
3
Natural Hazards
3
Zika
1
Chapitre 50. Le texte traite du paludisme grave, une forme sévère du paludisme principalement causée par Plasmodium falciparum. Il explique les circonstances dans lesquelles le diagnostic doit être évoqué, notamment en cas de fièvre au retour d'une zone tropicale. Le document décrit les exam...
Ce document intitulé « Diagnostic, traitement et prévention du paludisme : directive pour le personnel médical », publié par les Nations Unies en avril 2019, fournit des recommandations pratiques pour le personnel médical travaillant dans des zones à risque de paludisme. Il décrit les signe...
La thèse de Yobouet Inès Kouakou, soutenue à l’Université Claude Bernard Lyon 1, porte sur le traitement d’urgence du paludisme sévère chez l’enfant à l’aide d’une administration intranasale d’artésunate. L’objectif principal de ce travail est d’explorer, in vitro, la voie na...
English and French.
WEEKLY EPIDEMIOLOGICAL RECORD, NO 37, 13 SEPTEMBER 2024, 505-524
ince the introduction of multidrug therapy (MDT), there has been significant progress in reducing the prevalence of leprosy and the occurrence of new cases. Global strategies have evolved with progress in reducing the disease burden. Encouraged by the decrease in the number of cases on treatment, th...
Le Guide d'apprentissage 2 est destiné à tous les agents de santé qui auraient à prendre en charge des complications pour la lèpre. Il contient des conseils pratiques pour la reconnaissance des réactions lépreuses et leur traitment correct. Il comprend aussi des conseils pour la référence e...
This booklet offers tips for people affected by leprosy who want to prevent disability.
Meeting the rehabilitation needs of people affected by leprosy and promoting quality of life.
Disability Inclusive Development Toolkit
recommended
This toolkit is designed as a resource for CBM that can be used in a variety of ways: to support staff induction, team meetings, refresher days and training workshops. It can also be used as a tool for personal reflection and self-study. Tips for those intending to use it as a training resource are ...
The meeting of leprosy programme managers in the South-East (SE) Asia Region was convened by the WHO Regional Office for South-East Asia (WHO-SEARO) from 11 to 13 April 2023 in Kolkata, India. The meeting was attended by 40 participants, including 15 national focal points from nine countries, five e...
Leprosy will be eliminated when we detect all patients and cure them by using multidrug therapy (MDT).
Elimination means bringing the disease burden down to a very low level. This will lead to a reduction in the source of infection, so that leprosy is likely to disappear naturally as it already h...
La Polychimiothérapie (PCT) guérit la lèpre, interrompt la transmission et prévient les infirmités. La PCT est disponible gratuitement dans tous les centres de santé.
Available in: English, French, Chinese, Spanish, Russian, Arabic, Thai, Korean, Tajik, Vietnamese, Uzbek
http://www.who.int/disabilities/cbr/guidelines/en/
General Questionnaire. Participation Scale
A national overview with a case study from Cam Le district
The overall aims of this study are (1) to assess the extent to which social protection systems in Vietnam address the needs of people with disabilities; and (2) to identify and document elements of good practice, as well as challenges, ...
The overall aims of this study are (1) to assess the extent to which social protection systems in Vietnam address the needs of people with disabilities; and (2) to identify and document elements of good practice, as well as challenges, ...
The Participation Scale (P-scale) is a scale to measure (social) participation for use in rehabilitation, stigma reduction and social integration programmes
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success.
The NTLP is ...
The World Health Organization (WHO) organized the first global meeting on skin-related neglected tropical diseases (skin NTDs) at its headquarters in Geneva, Switzerland on 27–31 March 2023. This 5-day hybrid meeting brought together more than 800 global experts, stakeholders and partners from 86 ...
The Global Leprosy Strategy 2021–2030 “Towards zero leprosy” was developed through a broad consultative process with all major stakeholders during 2019 and 2020. Valuable inputs were provided by national leprosy programme managers, technical agencies, public health and leprosy experts, funding...
